Targeting CD38 and BCMA in Myeloma: Evidence and Enhanced Outcomes with Innovative Therapies

Stay up-to-date on the latest safety and efficacy data of CD38- and BCMA-targeting therapies being used to treat multiple myeloma while prioritizing patient safety and toxicity management and learn how providers can address disparities in myeloma care, through an expert-written ClinicalThought commentary and a CME-certified on-demand webcast with an accompanying slideset.

Share

Program Content

Activities

CD38 mAbs in NDMM
CD38-Targeted Antibodies in Transplant-Eligible and Transplant-Ineligible Patients With Myeloma
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 24, 2024

Expires: July 23, 2025

Managing R/R MM
Antibody–Drug Conjugates, Bispecific Antibodies and CAR T-Cell Therapies in Relapsed/Refractory Multiple Myeloma
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 24, 2024

Expires: July 23, 2025

Disparities in MM
Health Disparities in Multiple Myeloma
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 24, 2024

Expires: July 23, 2025

Activities

CD38 and BCMA in Multiple Myeloma
Targeting CD38 and BCMA in Myeloma: Evidence and Enhanced Outcomes With Innovative Therapies
Video
Congratulations: You achieved a completion on 04/09/2022

Released: August 09, 2024

Expires: February 08, 2025

Activities

CD38 and BCMA as Targets in Myeloma
Key Insights on CD38 and BCMA as Targets for Therapy in Multiple Myeloma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 28, 2024

Expires: August 27, 2025

Faculty

cover img faculity

Craig Emmitt Cole, MD

Associate Professor of Medicine
Department of Oncology
Karmanos Cancer Institute
Wayne State University School of Medicine
Detroit, Michigan

cover img faculity

Thomas G. Martin, MD

Clinical Professor of Medicine
Associate Chief, Division of Hematology/Oncology
Co-Lead, Cancer Immunology and Immunotherapy Program
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California

cover img faculity

Noopur Raje, MD

Professor of Medicine
Harvard Medical School
Director, Center for Multiple Myeloma
Massachusetts General Hospital
Boston, Massachusetts

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Sanofi.

Sanofi